Author

A. Sarasini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:benchmarking· 1 Research Focus:differential expression· 1

Frequent Co-Authors

E. Percivalle· 2 shared A. Bonetti· 1 shared A. Chinali· 1 shared A. P. DiNapoli· 1 shared A. Piralla· 1 shared C. F. Perno· 1 shared C. S. Vismara· 1 shared C. Zierold· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Percivalle

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection

N. Sherina, A. Piralla, L. Du, H. Wan, M. Kumagai-Braesh, J. Andrell, S. Braesch-Andersen, I. Cassaniti, E. Percivalle, A. Sarasini, F. Bergami, R. Di Martino, M. Colaneri, M. Vecchia, M. Sambo, , Q. Pan-Hammarstrom

This study tracks SARS-CoV-2 specific B- and T-cell responses in convalescent patients 6-8 months post-infection, finding sustained memory cell responses despite declining antibody levels.

bioRxiv · Nov 6, 2020 · PreprintImmunology

Clinical And Analytical Performance Of An Automated Serological Test That Identifies S1/S2 Neutralizing IgG In Covid-19 Patients Semiquantitatively.

F. Bonelli, A. Sarasini, C. Zierold, M. Calleri, A. Bonetti, C. S. Vismara, F. A. Blocki, L. Pallavicini, A. Chinali, D. Campisi, E. Percivalle, A. P. DiNapoli, C. F. Perno, F. Balldanti

This paper evaluates an automated serological test for SARS-CoV-2 S1/S2 IgG antibodies, showing high sensitivity, specificity, and semiquantitative neutralizing capacity for clinical use.

Journal of Clinical Microbiology · Aug 24, 2020Peer-reviewedImmunology